Moleculin Biotech, Inc. (MBRX)

Moleculin Biotech Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	8.88	4.28	23.55	43.15	70.9
Cash & Short-Term Investments	8.88	4.28	23.55	43.15	70.9
Cash Growth	107.53%	-81.83%	-45.42%	-39.15%	367.30%
Other Current Assets	0.81	0.92	2.72	2.45	1.59
Total Current Assets	9.69	5.19	26.27	45.6	72.5
Net Property, Plant & Equipment	0.39	0.58	0.8	0.68	0.45
Other Intangible Assets	11.15	11.15	11.15	11.15	11.15
Other Long-Term Assets	0.9	-	-	-	-
Total Assets	22.13	16.93	38.22	57.42	84.09
Accounts Payable	3.51	2.03	2.5	2.1	1.36
Accrued Expenses	3.35	3.33	4.32	2.72	2.26
Total Current Liabilities	6.85	5.36	6.82	4.82	3.62
Long-Term Leases	0.22	0.36	0.47	0.34	0.06
Other Long-Term Liabilities	0.04	-	4.86	0.08	1.41
Total Long-Term Liabilities	0.27	0.36	5.33	0.41	1.48
Total Liabilities	7.12	5.72	12.14	5.23	5.1
Common Stock	0	-	0.03	0.03	0.03
Additional Paid-in Capital	221	183.69	157.65	153.99	151.73
Accumulated Other Comprehensive Income	0.01	-0.04	-0.01	0.01	0.04
Retained Earnings	-	-	-131.6	-101.84	-72.81
Total Common Shareholders' Equity	15.01	11.21	26.07	52.19	78.99
Shareholders' Equity	221.01	183.65	26.07	52.19	78.99
Total Liabilities & Equity	22.13	16.93	38.22	57.42	84.09
Total Debt	0.22	0.36	0.47	0.34	0.06
Net Cash (Debt)	8.66	3.92	23.08	42.81	70.84
Net Cash Growth	120.82%	-83.01%	-46.10%	-39.57%	371.83%
Net Cash Per Share	7.31	28.46	292.01	561.23	988.43
Book Value	15.01	11.21	26.07	52.19	78.99
Book Value Per Share	12.67	81.38	329.94	684.22	1102.19
Tangible Book Value	3.86	0.06	14.93	41.04	67.85
Tangible Book Value Per Share	3.26	0.44	188.87	538.07	946.64

Updated Mar 18, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q